{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:52:27Z","timestamp":1762005147710,"version":"3.40.5"},"reference-count":32,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2021,4,14]]},"abstract":"<jats:sec>\n<jats:title>Purpose:<\/jats:title>\n<jats:p>Acinetobacter baumannii is an opportunistic pathogen, and is among the most\nproblematic nosocomial infections as well as community-acquired infections. This retrospective\nstudy was conducted as an attempt to determine the prevalence of multidrug-resistant A. baumannii\n(MDRAB) isolates from the north and central Jordan area during 2018.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Patients\u2019 records provided by an accredited central private laboratory located in Amman,\nwere examined for A. baumannii isolates identified during this period. The isolates were\nidentified to the species level using the API-10S system and the antimicrobial sensitivity testing\nwas determined using the Kirby\u2013Bauer disc diffusion method.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 43 unduplicated isolates were obtained and classified according to clinical\nsampling source into: Group I (blood), Group II (urine) and Group III (wound, pus, sputum, bedsore\nand others). Total MDRAB isolates recorded were 29 (67.4 %). Resistance to imipenem was\nfound to be 36% and 94% among groups II and III, respectively, and resistance to meropenem was\n60% and 88% among the same groups, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> Antimicrobial stewardship programs at a national scale are needed to calculate the\nactual proportion of MDRAB in the country and to combat its increasing emergence and decrease\nthe magnitude of antibiotic resistance.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871526519666191211144344","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T09:38:01Z","timestamp":1576661881000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of Multi-drug Resistant Acinetobacter baumannii (MDRAB) in Amman Jordan During 2018"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4111-4210","authenticated-orcid":true,"given":"Layla","family":"El-khatib","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, School of Science, The University of Jordan, Amman, 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2964-8324","authenticated-orcid":true,"given":"Saed","family":"Al-Dalain","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Mutah University, Al-Karak, 61710, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4618-1073","authenticated-orcid":true,"given":"Rama","family":"Al-Matarneh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Mutah University, Al-Karak, 61710, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-9802","authenticated-orcid":true,"given":"Sara","family":"Al-Bustanji","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Mutah University, Al-Karak, 61710, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4476-9025","authenticated-orcid":true,"given":"Marwa","family":"Al-Dmour","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Mutah University, Al-Karak, 61710, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1933-0328","authenticated-orcid":true,"given":"Yara","family":"Al-Amarin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Mutah University, Al-Karak, 61710, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2244-4406","authenticated-orcid":true,"given":"Yasser","family":"Gaber","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Mutah University, Al-Karak, 61710, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5495\/wjcid.v3.i3.25","volume":"3","author":"Joshi S.G.","year":"2013","unstructured":"Joshi S.G.; Litake G.M.; Acinetobacter baumannii: An emerging pathogenic threat to public health. World J Clin Infect Dis 2013,3(3),25-36","journal-title":"World J Clin Infect Dis"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138360","volume":"10","author":"Stahl J.","year":"2015","unstructured":"Stahl J.; Bergmann H.; G\u00f6ttig S.; Ebersberger I.; Averhoff B.; Acinetobacter baumannii virulence is mediated by the concerted action of three phospholipases D. PLoS One 2015,10(9)","journal-title":"PLoS One"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1586\/14787210.2015.1025055","volume":"13","author":"Dexter C.","year":"2015","unstructured":"Dexter C.; Murray G.L.; Paulsen I.T.; Peleg A.Y.; Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert Rev Anti Infect Ther 2015,13(5),567-573","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1128\/JB.00906-15","volume":"198","author":"Weber B.S.","year":"2015","unstructured":"Weber B.S.; Harding C.M.; Feldman M.F.; Pathogenic Acinetobacter: from the cell surface to infinity and beyond. J Bacteriol 2015,198(6),880-887","journal-title":"J Bacteriol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2147\/IDR.S166750","volume":"11","author":"Asif M.","year":"2018","unstructured":"Asif M.; Alvi I.A.; Rehman S.U.; Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist 2018,11,1249-1260","journal-title":"Infect Drug Resist"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3349\/ymj.2011.52.6.879","volume":"52","author":"Lee K.","year":"2011","unstructured":"Lee K.; Yong D.; Jeong S.H.; Chong Y.; Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J 2011,52(6),879-891","journal-title":"Yonsei Med J"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/2049-632X.12125","volume":"71","author":"Antunes L.C.","year":"2014","unstructured":"Antunes L.C.; Visca P.; Towner K.J.; Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 2014,71(3),292-301","journal-title":"Pathog Dis"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0034-1398388","volume":"36","author":"Doi Y.","year":"2015","unstructured":"Doi Y.; Murray G.L.; Peleg A.Y.; Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin Respir Crit Care Med 2015,36(1),85-98","journal-title":"Semin Respir Crit Care Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/ijerph15010153","volume":"15","author":"Odsbu I.","year":"2018","unstructured":"Odsbu I.; Khedkar S.; Khedkar U.; Nerkar S.S.; Tamhankar A.J.; St\u00e5lsby Lundborg C.; High proportions of multidrug-resistant Acinetobacter spp. isolates in a district in Western India: a four-year antibiotic susceptibility study of clinical isolates. Int J Environ Res Public Health 2018,15(1),153","journal-title":"Int J Environ Res Public Health"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40121-016-0125-y","volume":"5","author":"Vijayakumar S.","year":"2016","unstructured":"Vijayakumar S.; Gopi R.; Gunasekaran P.; Bharathy M.; Walia K.; Anandan S.; Veeraraghavan B.; Molecular characterization of invasive carbapenem-resistant Acinetobacter baumannii from a tertiary care hospital in South India. Infect Dis Ther 2016,5(3),379-387","journal-title":"Infect Dis Ther"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ajic.2013.10.010","volume":"42","author":"Obeidat N.","year":"2014","unstructured":"Obeidat N.; Jawdat F.; Al-Bakri A.G.; Shehabi A.A.; Major biologic characteristics of Acinetobacter baumannii isolates from hospital environmental and patients\u2019 respiratory tract sources. Am J Infect Control 2014,42(4),401-404","journal-title":"Am J Infect Control"},{"key":"ref=12","volume":"8","author":"Qouzah H. F.","year":"2018","unstructured":"Qouzah H. F.; Hawari F.; Abu-Qatouseh L. F.; Shehabi A. A.; Occurrence and molecular characterization of metallo-\u03b2-lactamases (MBLs) among Acinetobacter baumannii isolates from cancer patients. Int. Arab. J. Antimicrob. Agents 2018,8(2)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"Magiorakos A.P.","year":"2012","unstructured":"Magiorakos A.P.; Srinivasan A.; Carey R.B.; Carmeli Y.; Falagas M.E.; Giske C.G.; Harbarth S.; Hindler J.F.; Kahlmeter G.; Olsson-Liljequist B.; Paterson D.L.; Rice L.B.; Stelling J.; Struelens M.J.; Vatopoulos A.; Weber J.T.; Monnet D.L.; Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012,18(3),268-281","journal-title":"Clin Microbiol Infect"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2478\/pjs-2013-0075","volume":"85","author":"Sieniawski K.","year":"2013","unstructured":"Sieniawski K.; Kaczka K.; Ruci\u0144ska M.; Gagis L.; Pomorski L.; Acinetobacter baumannii nosocomial infections. Pol Przegl Chir 2013,85(9),483-490","journal-title":"Pol Przegl Chir"},{"key":"ref=15","unstructured":"City population, Jordan. Available from: https:\/\/www.city population. de\/ Jordan-Cities.html"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2147\/IDR.S163944","volume":"11","author":"Mart\u00edn-Aspas A.","year":"2018","unstructured":"Mart\u00edn-Aspas A.; Guerrero-S\u00e1nchez F.M.; Garc\u00eda-Colchero F.; Rodr\u00edguez-Roca S.; Gir\u00f3n-Gonz\u00e1lez J-A.; Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality. Infect Drug Resist 2018,11,861-872","journal-title":"Infect Drug Resist"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"h1139","DOI":"10.1136\/bmj.h1139","volume":"350","author":"El Emam K.","year":"2015","unstructured":"El Emam K.; Rodgers S.; Malin B.; Anonymising and sharing individual patient data. BMJ 2015,350,h1139","journal-title":"BMJ"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","volume":"45","author":"Bauer A.","year":"1966","unstructured":"Bauer A.; Kirby W.; Sherris J. C.; Turck M.;  Antibiotic susceptibility testing by a standardized single disk method Am J Clin Pathol 1966,45(4_ts),493-496","journal-title":"Antibiotic susceptibility testing by a standardized single disk method Am J Clin Pathol"},{"journal-title":"CLSI SUPPLEMENT M100","year":"2017","key":"ref=19","unstructured":"Performance Standards for Antimicrobial Susceptibility Testing. 27th ed CLSI SUPPLEMENT M100 2017"},{"year":"2016","key":"ref=20","unstructured":"Antimicrobial Susceptibility Tests on Groups of Organisms or Agents for Which There Are No EUCAST Breakpoints Available from:\n                     ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/Www.Eucast.Org\/Guidance_Documents\/\">http:\/\/Www.Eucast.Org\/Guidance_Documents\/2016"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009947","volume":"5","author":"Ye J.J.","year":"2010","unstructured":"Ye J.J.; Huang C.T.; Shie S.S.; Huang P.Y.; Su L.H.; Chiu C.H.; Leu H.S.; Chiang P.C.; Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains. PLoS One 2010,5(4)","journal-title":"PLoS One"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1128\/JCM.01588-06","volume":"45","author":"Jones R.N.","year":"2007","unstructured":"Jones R.N.; Ferraro M.J.; Reller L.B.; Schreckenberger P.C.; Swenson J.M.; Sader H.S.; Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 2007,45(1),227-230","journal-title":"J Clin Microbiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.idc.2016.02.004","volume":"30","author":"Duin V.D.","year":"2016","unstructured":"Duin V.D.; Paterson D.L.; Multidrug-resistant bacteria in the community: trends and lessons learned. Infect Dis Clin North Am 2016,30(2),377-390","journal-title":"Infect Dis Clin North Am"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1128\/IAI.01958-14","volume":"82","author":"Ketter P.M.","year":"2014","unstructured":"Ketter P.M.; Guentzel M.N.; Schaffer B.; Herzig M.; Wu X.; Montgomery R.K.; Parida B.K.; Fedyk C.G.; Yu J-J.; Jorgensen J.; Chambers J.P.; Cap A.P.; Arulanandam B.P.; Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3. Infect Immun 2014,82(9),3910-3918","journal-title":"Infect Immun"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"828","DOI":"10.26719\/2015.21.11.828","volume":"21","author":"Batarseh A.","year":"2016","unstructured":"Batarseh A.; Al-Sarhan A.; Maayteh M.; Al-Khatirei S.; Alarmouti M.; Antibiogram of multidrug resistant Acinetobacter baumannii isolated from clinical specimens at King Hussein Medical Centre, Jordan: a retrospective analysis. East Mediterr Health J 2016,21(11),828-834","journal-title":"East Mediterr Health J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1089\/mdr.2019.0018","volume":"25","author":"Shah M.W.","year":"2019","unstructured":"Shah M.W.; Yasir M.; Farman M.; Jiman-Fatani A.A.; Almasaudi S.B.; Alawi M.; El-Hossary D.; Azhar E.I.; Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of Acinetobacter baumannii in Western Saudi Arabia. Microb Drug Resist 2019,25(9),1297-1305","journal-title":"Microb Drug Resist"},{"key":"ref=27","first-page":"803","volume":"54","author":"Hussein N.H.","year":"2013","unstructured":"Hussein N.H.; Al-Mathkhury H.J.F.; Sabbah M.A.; Imipenem-Resistant Acinetobacter baumannii isolated from patients and hospitals environment in Baghdad. Iraqi J Sci 2013,54(4),803-812","journal-title":"Iraqi J Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ajic.2011.09.019","volume":"40","author":"Hamzeh A.R.","year":"2012","unstructured":"Hamzeh A.R.; Al Najjar M.; Mahfoud M.; Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria. Am J Infect Control 2012,40(8),776-777","journal-title":"Am J Infect Control"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/jac\/dkt109","volume":"68","author":"Espinal P.","year":"2013","unstructured":"Espinal P.; Poirel L.; Carmeli Y.; Kaase M.; Pal T.; Nordmann P.; Vila J.; Spread of NDM-2-producing Acinetobacter baumannii in the Middle East. J Antimicrob Chemother 2013,68(8),1928-1930","journal-title":"J Antimicrob Chemother"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5740\/jaoacint.16-0139","volume":"100","author":"Ali H.M.","year":"2017","unstructured":"Ali H.M.; Salem M.Z.M.; El-Shikh M.S.; Megeed A.A.; Alogaibi Y.A.; Talea I.A.; Investigation of the virulence factors and molecular characterization of the clonal relations of multidrug-resistant Acinetobacter baumannii isolates. J AOAC Int 2017,100(1),152-158","journal-title":"J AOAC Int"},{"key":"ref=31","unstructured":"Jordan, National Action Plan to Combat Antimicrobial Resistance In Hashemite Kingdom of Jordan (2018-2022). Available from"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e01110","DOI":"10.1128\/AAC.01110-18","volume":"63","author":"Isler B.","year":"2018","unstructured":"Isler B.; Doi Y.; Bonomo R.A.; Paterson D.L.; New treatment options against carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother 2018,63(1),e01110-e01118","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/177360","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/177360\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/177360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T14:34:20Z","timestamp":1634481260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/177360\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526519666191211144344","relation":{},"ISSN":["1871-5265"],"issn-type":[{"type":"print","value":"1871-5265"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}